Evidence map›Paper›PMID 29211708›Full record

ArticleNature2018

Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators.

Nian Liu, Cameron H Lee, Tomek Swigut, Edward Grow, Bo Gu, Michael C Bassik, Joanna Wysocka

Abstract read
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 239 papers.

0numbers the graph read from it
0cells of the map it votes in
239citing papers in PubMed
55.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

239 citing papers in PubMed, 362 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

179 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nian LiuDepartment of Chemical and Systems Biology, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Cameron H LeeDepartment of Genetics, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Tomek SwigutDepartment of Chemical and Systems Biology, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Edward GrowDepartment of Genetics, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Bo GuDepartment of Chemical and Systems Biology, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Michael C BassikDepartment of Genetics, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Joanna WysockaDepartment of Chemical and Systems Biology, Stanford School of Medicine, Stanford University, Stanford, California 94305, USA.
Stanford University · US

Funding

GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
Accelerating drug development and repurposing using systematic genetic interactioDP2HD084069 · NICHD · STANFORD UNIVERSITY · PI BASSIK, MICHAEL C · 2014 to 2014
$2.4M
Predicting causal non-coding variants in a founder populationR01HG008150 · NHGRI · STANFORD UNIVERSITY · PI MONTGOMERY, STEPHEN · 2015 to 2017
$1.4M
Mechanisms of enhancer activation in early developmentR01GM112720 · NIGMS · STANFORD UNIVERSITY · PI WYSOCKA, JOANNA · 2015 to 2018
$1.2M
Howard Hughes Medical InstituteNHGRI NIH HHS R01 HG008150NICHD NIH HHS DP2 HD084069NIGMS NIH HHS R01 GM112720NIGMS NIH HHS T32 GM007790NIH HHS 1UM1HG009436-01
6 · The paper itself

Abstract

Transposable elements, also known as transposons, are now recognized not only as parasitic DNA, the spread of which in the genome must be controlled by the host, but also as major players in genome evolution and regulation. Long interspersed element-1 (LINE-1, also known as L1), the only currently autonomous mobile transposon in humans, occupies 17% of the genome and generates inter- and intra-individual genetic variation, in some cases resulting in disease. However, how L1 activity is controlled and the function of L1s in host gene regulation are not completely understood. Here we use CRISPR-Cas9 screening strategies in two distinct human cell lines to provide a genome-wide survey of genes involved in the control of L1 retrotransposition. We identify functionally diverse genes that either promote or restrict L1 retrotransposition. These genes, which are often associated with human diseases, control the L1 life cycle at the transcriptional or the post-transcriptional level in a manner that can depend on the endogenous L1 nucleotide sequence, underscoring the complexity of L1 regulation. We further investigate the restriction of L1 by the protein MORC2 and by the human silencing hub (HUSH) complex subunits MPP8 and TASOR. HUSH and MORC2 can selectively bind evolutionarily young, full-length L1s located within transcriptionally permissive euchromatic environments, and promote deposition of histone H3 Lys9 trimethylation (H3K9me3) for transcriptional silencing. Notably, these silencing events often occur within introns of transcriptionally active genes, and lead to the downregulation of host gene expression in a HUSH-, MORC2-, and L1-dependent manner. Together, these results provide a rich resource for studies of L1 retrotransposition, elucidate a novel L1 restriction pathway and illustrate how epigenetic silencing of transposable elements rewires host gene expression programs.

Indexed as

Gene SilencingAnimalsCRISPR-Cas SystemsEmbryonic Stem CellsEuchromatinGenome, HumanGenomicsHumansK562 CellsLong Interspersed Nucleotide ElementsMaleMiceMultiprotein ComplexesNuclear ProteinsPhosphoproteinsProtein SubunitsEuchromatinMORC2 protein, humanMPHOSPH8 protein, humanMultiprotein ComplexesNuclear ProteinsPhosphoproteinsProtein SubunitsTASOR protein, humanTranscription Factors

Identifiers

PMID29211708
PMCPMC5774979
OpenAlexW2775351627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.